Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership
Oslo, Norway, December 19, 2022 โ Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that it has entered into a strategic manufacturing partnership with Richter-Helm BioLogics GmbH & Co KG to supply plasmid DNA for Nykodeโs wholly owned and partnered product portfolio.